. 2015.
. 2014.
“Assessment Of Viral Inhibition Activity In Low Seroprevalent Adenovirus-35 Vectored Hiv Vaccines +/- Adjuvanted Protein Or Electroporated Dna”. In Hiv Research For Prevention 2014: Aids Vaccine, Microbicide And Arv-Based Prevention Science (Hivr4P). Hiv Research For Prevention 2014: Aids Vaccine, Microbicide And Arv-Based Prevention Science (Hivr4P). Cape Town, SA. http://hivr4p.org/.
. 2014. “Clinical Safety And Immunogenicity Of Two Hiv Vaccines Sev-G(Np) And Ad35-Grin In Hiv-Uninfected, Healthy Adult Volunteers”. In Hivr4P (Hiv Research For Prevention). Hivr4P (Hiv Research For Prevention). Cape Town, South Africa. http://hivr4p.org/.
. 2014. . 2010.
. 2010.
. 2008.
“A Cross-Sectional Study In Eastern And Southern Africa To Characterize Laboratory Reference Intervals In Healthy Adults For Hiv Prevention Trials”. In Aids Vaccine 2008 Conference. Aids Vaccine 2008 Conference. Cape Town, South Africa. http://www.vaccineenterprise.org/conference_archive/2008/index.html.
. 2008. “Challenges Of Use And Compliance With Effective Contraceptives Among Female Participants In Preventive Hiv Vaccine Trials: The Kenyan Experience”. In Aids Vaccine 2007 Conference. Aids Vaccine 2007 Conference. Seattle, WA. http://www.vaccineenterprise.org/conference_archive/2007/index.html.
. 2007. “Phase 2A Dose And Route Study Of A Dna Prime Mva Boost Vaccine Candidate”. In Aids Vaccine 2005 International Conference. Aids Vaccine 2005 International Conference. Montreal, Quebec, Canada.
. 2005.